Very early exposure to even a very small dose of herpes simplex virus (HSV) in infant mice can lead to cognitive decline later in life, according to findings from a new Dartmouth-led study, published in the journal PLoS Pathogens. This is significant because of emerging data in human studies showing an association between HSV and Alzheimer’s disease in humans.
Findings from a new Dartmouth-led study, published in the journal mBio, highlight key differences in the gut microbiome of infants with cystic fibrosis (CF) compared to that of healthy infants, and how these alterations may adversely affect their health.
Geisel researcher Paul Barr, PhD, MSc, discusses his work to improve patient outcomes through the development of new tools to enhance communications between patients and their healthcare providers.
Findings from a new study, conducted by a team of researchers at Dartmouth’s Geisel School of Medicine and collaborating institutions and published in the journal e-clinical Medicine, a member of the Lancet family of journals, show beneficial effects on functionally important respiratory symptoms when persons who smoke switch completely to e-cigarettes.
On October 29, nearly 200 members of the local, national, and international digital health community—including researchers, clinicians, healthcare administrators, payors, investors, experts from government and industry, and students and trainees—gathered for a daylong meeting at Dartmouth College to discuss the expanding field of digital therapeutics.
The Center for Technology and Behavioral Health (CTBH) at the Geisel School of Medicine at Dartmouth has announced an innovative collaboration with Boehringer Ingelheim with the goal of advancing prescription digital therapeutics that specifically target serious mental illness.
A new Dartmouth-led study, published in the journal BMC Public Health, shows that even small effects from environmental exposures to toxins like air pollution, PFAS (forever chemicals), and arsenic in well water can adversely affect the health of vulnerable groups like mothers and their babies.
Two teams of researchers at Dartmouth’s Geisel School of Medicine and Thayer School of Engineering, led by David Leib, PhD, and Margaret Ackerman, PhD, will be among the recipients of grant funding from the federal Advanced Research Program for Health (ARPA-H) to support innovations in pandemic preparedness and vaccine generation.
On Wednesday, September 18, Geisel School of Medicine and Dartmouth Health (DH) celebrated their first-ever Biomedical Research Day. The landmark event, held at Dartmouth Hitchcock Medical Center (DHMC), was a celebration of the breadth and impact of the institution’s research enterprise and was marked by strong attendance with well over 260 faculty and trainees taking part.
Dartmouth Health’s Dartmouth Hitchcock Medical Center received a $27.7 million, seven-year grant from the National Institutes of Health (NIH) to fund projects that will speed the implementation of proven medical innovations as part of a national consortium of biomedical research centers.
Upcoming EventsThis page may link to PDF files. Use this link to download Adobe Reader if needed.